Table 1.
Characteristics of participants.
| Alcohol Swab (n = 85) | Control (n = 85) | p-value* | |
|---|---|---|---|
| Age (years) | 5.6 (5.1) | 5.9 (5.6) | 0.71 |
| Male sex | 45 (53) | 51 (60) | 0.35 |
| Ethnicity | 0.84 | ||
| Caucasian | 36 (42) | 37 (44) | |
| Asian | 27 (32) | 29 (34) | |
| Other | 22 (26) | 19 (22) | |
| Only one | 44 (52) | 49 (58) | 0.23 |
| vaccination** | |||
| Pediacel® | 21 | 19 | - |
| Bexsero® | 17 | 13 | - |
| Prevnar® 13 | 13 | 17 | - |
| Gardasil® 9 | 13 | 14 | - |
| Flulaval® | 13 | 12 | - |
| Fluzone® | 12 | 13 | - |
| Twinrix® | 6 | 9 | - |
| Menjugate® | 6 | 8 | - |
| Priorix® | 7 | 7 | - |
| Adacel®-Polio | 9 | 4 | - |
| Priorix-TetraTM | 4 | 4 | - |
| Varivax® | 4 | 4 | - |
| Adacel® | 2 | 5 | - |
| ProQuad® | 6 | 1 | - |
| Varilrix® | 2 | 3 | - |
| Engerix®-B | 2 | 2 | - |
| Menactra® | 2 | 1 | - |
| Recombivax HB® | 2 | 1 | - |
| Boosterix®-polio | 1 | 1 | - |
| M-M-R®II | 0 | 1 | - |
Results are mean (standard deviation) or frequency (percent)
*Chi-squared test or t-test
**Participants received between 1 and 4 vaccinations. In total 279 vaccine doses were administered, 237 were administered intramuscularly, 119 swab vs. 118 control and 42 were administered subcutaneously, 23 swab vs. 19 control